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Objectives. This study was undertaken to determine whether
abnormalities in exercise capacity or ventricular function persist
recovery
acute dbW cardlonay thy.
free Persistent ventricular structural abnormalities
r. f : in .
Me". The results of rest and esrdse first-pass radionu-
elide ventrieul play in 18 patients who were seen within 6
maths of the onset of led cardiomyopathy and subsequently
had a ventricular ejectionrest left were compared
*0 those of r ed control subjects
.
Res . Patients were studled 144 t 34 (mean t SEM) days
after the onset of left ventricular d at a time when heart
failure symptoms had resolved. Patients with myocyle necrosis, as
assessed by endomyocardial biopsy (n = 13) or antinayosin scln®
y (n = 12), recovered more rapidly than did thim without
necrosis. Oxygen cons both at peak exercise (17.7 t 1 .2
vs. 26.1 t 1.5 mllkg per min, p < 0.05) toad at the anaerobic
Dilated cardiomyopathy is a significant cause of cardiovas-
cular morbidity and mortality, particularly atriong men and
women <50 years of age (1). Patients with acute dilated
ca diomyopathycan present with clinical syndromes ranging
from asymptomatic cardiomegaly to life-threatening ventric-
ular arrhythmias or cardiogenic shock (2,3) . Survivors of
dilated cardiomyopathy frequently have symptomatic heart
failure leading to a decrease in exercise tolerance and
disability (1) .
Previous natural history studies of dilated cardiomyopa-
thy (4-6) were typically performed before the routine use of
vasodilator therapy, examined only cumulative survival
rates and did not provide longitudinal data on hemodynamic
status or ventricular function. Although most patients with
this disorder die of progressive heart failure or arrhythmia
within 5 years of diagnosis, several recent studies (3,6) have
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threshold (11 .1 t 0.5 vs.17.1 ± 1,3 wllkg per groin, p < 0.05) was
lower in the patients who had recovered front rdiorayopaathy
than in control subjects. Rest and exercise end-systolic and
end-diastolic left ventricular volumes were greater in the patients
than its the control subjects, although stroke voha nes were simi-
lar. Left ventricular filling at rest was lower at diastolic filling
intervals of 40% and 90%, and rest and exercise left vents r
early peak filling rate normalized for end-diastolic volume was
slower in the patients don in the control subjects . At long-term
follow-up of 1, 2 t 206 days, two patients had a return of heart
failure symptoms and a decrease in left ventricular ejection
fraction .
Conclusions. Despite the apparent normalization of rest left
ventricular ejection fraction, patients who have recovered from
dilated iomyopaathy have abnormalities in aerobic exercise
capacity and in left ventricular systolic and diastolic performance .
(J Am Coil Cardiol 1994;24.462-70)
reported a subgroup of patients who demonstrate spontane-
ous improvement in ventricular function . The improvement
seen in some patients is not surprising, as many of the pos-
sible causes of acute or subacute ventricular dysfunction,
including the effects of toxins (alcohol, cobalt), inflammation
(viral myocarditis, sarcoidosis) and metabolic derangements
(hypothyroidism, pheocbromocytoma), may be reversible .
The long-term clinical and hemodynamic sequelae after
recovery from acute dilated cardiomyopathy have not been
characterized, in particular among those patients in whom
rest left ventricular function has recovered to normal. Knowl-
edge of any persistent myocardial dysfunction is important, as
appropriate pharmacologic therapy may be able to delay the
onset or prevent the recurrence of symptomatic heart failure
(7). Therefore, this study was undertaken to determine whether
abnormalities in exercise capacity or ventricular systolic or
diastolic function persist in patients whose rest left ventricular
ejection fraction normalized after an episode of acute dilated
cardiomyopathy .
Methods
Patients . The study patients were identified from a larger
group of approximately 300 patients referred to the Heart
0735-1097194/$7.00
Failure Service of the Massachusetts General Hospital be-
tween July 1, 1986 and June 30, 1992 for diagnostic evalua-
tion of acute onset dilated cardiomyopathy . From a review
of the medical records of the referral group, we identified 18
patients (9 men and 9 women) who presented <6 months
after the onset of acute dilated cardiomyopathy and subse-
quently demonstrated normal left ventricular ejection frac-
tion at rest as measured by routine echocardiographic or
radionuclide techniques (Table 1) . All study patients had
initially presented with a left ventricular ejection fraction
:sO.40 due to diffuse or multifocal wall motion abnormalities
and subsequently demonstrated both an ejection fraction
2:0.50 and resolution of wall motion abnormalities by equi-
librium radionuclide ventriculography . Results of coronary
angiography were normal in 13 patients ; minor stenoses
were present in 3 (40% stenosis in the left anterior descend-
ing artery in Patient 5, 30% stenosis of the left anterior
descending artery in Patient 13 and 40% stenosis in the left
anterior descending diagonal branch in Patient 15). Two
patients (Patients 9 and 16) who did not undergo coronary
angiography were <40 years old and had normal findings on
exercise thallium study . Patients were excluded if they had a
history of valvular heart disease, uncontrolled hypertension
or left ventricular outflow tract obstruction .
Initial medical therapy consisted of digoxin, loop diuret-
ics and converting enzyme inhibitor therapy (either captoprill
or enalapril) for symptomatic patients . Patients were advised
to avoid extreme physical exertion . Three of the four pa-
tients with biopsy-verified myocarditis received a 6-month
course of immunosuppressive therapy as described later .
Ate = alcoholism ; AM = antimyosin ; DCM = dilated cardiomyopathy; F = female ; IF = interstitial fibrosis ; LVEF = left ventricular ejection fraction ; M = male;
MH = myocyte hypertrophy ; Myo = myorardifis ; N1 = normal myocardium; PP = postpartum ; Pt = patient; - = negative ; + = positive ; - - - = not performed.
Follow-up endomyocardial biopsy in all cases revealed res-
olution of myocarditis with a modest degree of interstitial
fibrosis present .
The normal control group was composed of 18 volunteers
(9 men and 9 women) with no cardiac symptoms and normal
findings on physical examination and electrocardiography at
rest and during exercise ; none was receiving cardiac medi-
cations . These subjects had a mean age of 37 ± 3 .0 years
(p = NS vs. the mean age in the patient group) and an age
range (28 to 64 years) similar to that of the patient group (29
to 69 years) .
Transvenous right ventricular biopsy and pathologic exam-
ination. Thirteen patients (Patients I, 2, 4 to 6, 10 to 15, 17
and 18) underwent right ventricular biopsy by means of the
right internal jugular vein as previously described (8) . All
biopsy specimens (five to seven from each patient, each
measuring 2 to 3 mm in diameter) were examined by two
observers, and the reported results represent their mutually
agreed upon interpretation . Specimens defined as showing
myocarditis according to the Dallas criteria contained an
inflammatory infiltrate adjacent to necrotic or degenerating
myocytes with a varying amount of interstitial fibrosis (9) .
Normal specimens showed no diagnostic abnormalities, in-
cluding myocyte hypertrophy or interstitial or replacement
fibrosis .
Immunosuppressive therapy. Three patients (Patients 1,
10 and 15) with biopsy-verified myocarditis were treated
with immunosuppressive therapy for 6 months according to
the protocol of the Myocarditis Treatment Trial (10) . All
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Table 1 . Demographic Data for Cardiornyopathy Group
Pt
No.
Age (yr)i
Gender
Initial
Clinical
Diagnosis
Presenting
Symptom
Time to
Normal
LVEF (days)
Ejection Fraction
Initial
AM
Recovered Biopsy Scan
1 441F DCM Shock 33 0 .34 0 .62 Myo +
2 43fM Ale Shock 339 0.20 0 .51 MH
3 6WM 0CM Heart failure 165 0 .13 0.56 . . .
4 34M DCM Heart failure 98 0 .15 0 .54 IF
5 401M DCM Heart failure 152 0 .25 0.60 MH, IF +
6 4311F ,Ale Heart failure 541 0 .17 0 .58 MH, IF
7 571M Ate None 140 0 .34 0 .50
8 AM DCM Shock 10 0 .13 0 .74 +
9 29im DCM Heart failure 8 0 .38 0 .82
. . .
+
10 311M DCM Chest pain 32 0 .40 0 .70 Myo +
11 331F DCM Heart failure 271 0 .23 0 .52 Myo
12 671F DCM Heart failure 31 0 .30 0 .65 MH, IF +
13 69iM 0CM Heart failure 361 0 .33 0 .65 NI +
14 36/F DCM Heart failure 113 0 .20 0 .60 MH
15 70/F DCM Chest pain 95 0 .40 0 .57 Myo
16 NO 0CM Heart failure 148 0 .30 0.65
. . .
17 371F DCM Cheat pain 63 0 .40 0 .58 N1
18 26/F PP Heart failure 7 0 .35 0 .53 NI
Mean 45 144 0 .28 0 .61
SEM 3 .5 34 0 .02 0 .02
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treated patients underwent repeat biopsy, which disclosed
resolution of tt>E myocarditis .
Indium-111 oral antimyosin cardiac scintigraphy
.
Monoclonal antimyosin Fab fragments radiolabeled with
indium-Ill (Centocor) were administered to 12 patients
(Patients 1, 2, 4-to 6, 8 to 10, 12, 13, 17 and 18) as previously
described (11) . Ungated planar and single-photon emission
computed tomographic images were obtained 48 to 72 h after
the administration of radioactive agent and were interpreted
by at least three observers who had no prior knowledge of
clinical or biopsy results
. The results of the antimyosin
scintigraphic imaging were classified as either normal or
abnormal, quantitative analysis of image intensity was not
performed
. A scan was defined as abnormal when focal or
diffuse uptake of tracer was present in the planar image and
in at least two of the three tomographic reconstructions .
C e tuft. Upright bicycle exer-
cise was performed on an electronically braked bicycle
ergometer (pedal-mode ergometer ; Warren E
. Collins, Inc .)
at a constant cycle speed of 60 rpm using a continuous ramp
protocol in which work load increased continuously by
25 Wimin up to peak tolerance . Heart rate, blood pressure
and the 12-lead electrocardiogram (ECG) were monitored
continuously . Peak work load in watts and exercise duration
in minutes were noted . All subjects exhaled into a mixing
chamber from which an aliquot of mixed expired gas was
sampled every 15 s, dried and analyzed for oxygen (Beck-
man OMI, Beckman Instruments Inc .) and carbon dioxide
(Beckman LB2) content. Oxygen uptake, carbon dioxide
output, respiratory quotient, minute ventilation and the venti-
latory equivalent for oxygen were calculated by on-line com-
puter as previously reported (12)
. Anaerobic threshold was
determined by gas exchange criteria as the point of nonlinear
increase in the ventilatory equivalent for oxygen, which has
previously been associated with elevations in simultaneously
obtained arterial lactate samples (13) . Predicted values for
maximal oxygen consumption during upright bicycle exer-
cise were calculated from a gender-specific regression equa-
tion incorporating age, height and weight (14) . At the time of
exercise testing, two patients (Patients 11 and 12) were
receiving digoxin for control of supraventricular arrhythmias
and eight (Patients 2, 6, 7, 11, 12, 14, 17 and 18) were still
receiving vasodilator therapy. Vasodilator therapy was with-
held for 12 h before testing.
ionudide a phy. First-pass radionuclide an-
giography was performed with a multicrystal gamma camera
(Baird-Atomic System 77) in the anterior view with the
patient upright at rest and at peak exercise . Twenty minutes
after pretreatment with 3 ml of stannous pyrophosphate,
10 mCi of technetium-99m pertechnetate dissolved in < l ml
of normal saline solution was injected in an antecubital vein
and immediately flushed with 20 ml of normal saline solu-
tion. Data were acquired at 25-ms intervals as the radionu-
clide bolus entered the central circulation
. The first transit of
the bolus through the major vessels and heart chambers was
stored on a minicomputer system associated with the earn-
era. The entire study was completed within 50 s . At peak
exercise, a second bolus of 15 mCi of technetium-99m
pertechnetate was administered
. Data were similarly ac-
quired at 25-ms intervals and stored for analysis
.
The data were analyzed with use of MAC77 software,
(Scinticor Inc). A region of interest was placed over each
ventricle and a time-activity curve generated . Peak activity
was considered to be end-diastole and the activity minimum
was considered to be end-systole . Only cycles with >70%
of the maximal end-diastolic activity in the end-diastolic
frame were included for analysis . Background was taken as
the activity within the ventricular region of interest before
the first ventricular beat . The background-subtracted ven-
tricular beats were summated to generate a single represen-
tative cardiac cycle . The right and left ventricular ejection
fractions were derived from time-activity curves as (End-
diastolic counts - End-systolic counts)/End-diastolic counts .
Prior studies from our laboratory have demonstrated an inter-
observer error for this calculation of the ejection fraction of
0.04 (15). The left ventricular end-diastolic and end-systolic
volumes were calculated from the regions of interest with the
use of a single-plane area-length method and divided by the
body surface area to obtain the left ventricular end-diastolic
volume index and end-systolic volume index . Left ventricular
stroke volume index was calculated as End-diastolic volume
index - End-systolic volume index .
Diastolic function studies . Radionuclide left ventricular
fractional filling curves were generated by dividing the
diastolic time interval for each patient into 10 equal periods
and plotting each interval against the simultaneous cumula-
tive filling fraction (Counts at the time - End-systolic
counts) - l00/(End-diastolic counts -- End-systolic counts),
as previously described (16) . Linear interpolation was per-
formed between points in the raw data curve to determine
filling at each 10% .
Left ventricular peak filling rates were obtained by a
method previously described (16) . Peak filling rates were
normalized by end-diastolic counts and by stroke counts and
expressed in end-diastolic volumes/s and stroke volumes/s
(17). Time to peak filling rate was calculated as Time at peak
filling rate - Time at end-systole and was expressed in ms .
The atrial contribution to filling was derived from time-
activity curves as the percent of diastolic filling occurring
during atrial systole . Atrial systole was defined as occurring
from the beginning of the PR interval + 40 ms (electrome-
chanical delay) until end-diastole (17) . Percent atrial contri-
bution to filling was calculated as Atrial filling contribution x
100/Filling volume .
Clinical follow-up, All patients were seen on a regular
basis after their initial evaluation for dilated cardiomyopa-
thy . Visits consisted of a review of systems, physical exam-
ination and review of current medications . Diuretic agents
were discontinued after lessening of congestive symptoms
and improved left ventricular systolic function. Repeat as-
sessment of left and right ventricular ejection fraction was
performed only when indicated by a change in clinical status .
JACC Vol . 24, No. 2
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Statistical analysis . Group data are expressed as mean
value ± SEM . Comparison between two groups of dichoto-
mous variables was performed with the Fisher exact test .
Differences between rest and exercise variables within the
control and patient groups were compared using two-way
analysis of variance followed by a Newman-Keuls multiple
comparison test. Differences between patient groups were
compared using a one-way analysis of variance followed by a
Newman-Keuls multiple comparison test . Differences were
considered significant at a level of p < 0.05 .
Resilits
Study patients and clinical course (Table 1) . The group
with a history of cardiomyopathy comprised nine men and
nine women with a mean age of 45 ± 4 years, The initial left
ventricular ejection fraction, assessed either noninvasively
or by left ventriculography, was 0 .28 ± 0 .02 (range 0.13 to
0,40). The majority (14 patients P8%D presented with symp-
tomatic heart failure ; of these, 3 patients had cardiogenic
shock. Three patients (17%) presented with the sudden onset
of chest pain and ECG abnormalities mimicking acute myo-
cardial infarction despite normal coronary anatomy, and one
patient (5%) had asymptomatic cardiomegaly on a routine
chest X-ray study . The potential ,tiology of the dilated cardio-
myopathy before evaluation was clinically suspected myo-
carditis in 14 patients (78%) and alcoholic cardiomyopathy in
3 (17% ; all 3 of the latter patients had been heavy consumers
of alcoholic beverages for >10 years. There was a single
case of postpartum cardiomyopathy. One patient (Patient 8)
suspected to have myocarditis developed cardiogenic shock
<24 h after orthotopic liver transplantation .
Four of the 13 patients who underwent diagnostic right
ventricular biopsy were found to have unequivocal myocar-
ditis . Antimyosin scintigraphy revealed myocardial uptake
in 8 of the 12 study patients, 3 of whom had a concurrent
right ventricular biopsy that did not indicate myocarditis .
At the time of recovery from dilated cardiomyopathy, left
ventricular ejection fraction at supine rest ranged from 0 .50
to 0.82 (mean 0.61 ± 0.02). No patient had developed
significant mitral regurgitation, as assessed by echocardiog-
raphy (Patients I to 4, 7 to 9, 11 and 15 to 18) or by physical
examination (Patients 5, 6, 10 and 12 to 1.4) . Although the
interval between initial and repeat assessment of ventricular
function averaged 144 ± 34 days, 3 patients, all with positive
findings on antimyosin scan, showed improvement within 10
days of symptom onset to a mean left ventricular ejection
fraction of 0 .70 ± 0.09. Patients who had had evidence for
ongoing myocardial injury (either positive findings on an-
timyosin scan or evidence for myocarditis on endomyocar-
dial biopsy) were more likely to recover within 5 weeks of
the onset of symptoms than were those patients whose scan
or biopsy did not show injury (6 of 10 vs. 0 of 4, p < 0.05) .
Among the patients who underwent antimyosin scintigra-
phy, the time to recovery from symptom onset was more
Table 2
. Hemodynamic and Gas Exchange Data
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%, predicted peak 0, consumption
43 :t 3 33 ± 2t
*p <0 .05, exercise versus rest . t p <0.05, cardiomyopathy versus control
group . AT = anaerobic threshold ; DBP = diastolic blood pressure ; MR
heart rate ; 0 2 = oxygen; SBP " systolic blood pressure .
rapid in those with positive than in those with negative scan
findings (68 ± 33 vs. 269 ± 112 days, p < 0 .05) .
Long-term clinical and echocardiographic follow-up data
were available for all patients at a mean of 1,082 ± 206 days
after presentation . Two patients (Patients I I and 12) devel-
oped recurrent New York Heart Association functional class
11 symptoms of heart failure and had a decrease in mean left
ventricular ejection fraction to 0.39 ± 0 . 01 . All other patients
remained in functional class I with a mean left ventricular
ejection fraction of 0 .60 ± 0.03. No deaths have occurred .
Exercise capacity and gas exchange (Table 2) . All patients
had sinus rhythm at the time of study . The patient and
normal groups had similar values for rest and exercise peak
heart rate and exercise systolic and diastolic blood pres-
sures. Systolic blood pressure at rest was lower in the
normal subjects than in the patients (102 ± 4 vs . 125 ±
5 mm Hg, p < 0 .05). There was no difference in peak work
load achieved during exercise between the patients and the
control subjects (130 ± 15 vs, 132 ± 11 W) .
Oxygen consumption at peak exercise was lower in the
patients than in the control group . This difference was
particularly marked when expressed as a fraction of pre-
dicted oxygen consumption for age, gender, height and
weight . Oxygen consumption at the anaerobic threshold was
also lower in the patients than in the control group, both in
absolute terms and as a fraction of maximal predicted
oxygen consumption . There was no difference in exercise
capacity or any measured hemodynamic or ventriculo-
graphic variable between patients who were or were not
receiving long-term vasodilator therapy .
Rest and exercise systolic ventricular function . The results
of first-pass radionuclide angiography are described in
Table 3 . Left ventricular ejection fraction at rest was higher
in the control subjects than in the patients and this difference
Control
Group
cardiomynpalhy
Croup
HR (beats/mint
Rest 82 ± 3 75±3
Exercise 159 a 4* 151 ± 5*
SBP (mm Hg)
Rest 102 ± 4 125 ± 5t
Exercise 163 ± 7* 175 ± 7*
DBP (mm Hg)
Rest 69 ± 3 71 ± 2
Exercise 79 ± 3* 85 ± 3*
Peak work load (W) 132 ± It 130 ± 15
Peak 0 2 consumption (mllkg per ruin)
Actual 26 .1 a 1 .5 17 .7 ± 1 .2t
17r predicted 82 16 53 ± 3t
0, consumption at AT (mlikg per niin)
Actual PA 1,3 nA ± 0 .5 ;
466
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3. Radionuclide Angiographic Assessment of Systolic and
Diastolic Function
'p < 0
.05, exercise versus rest . t p < 0,05 cardiomyopathy versus control
group, EDY and EDVI
-
end-diastolic volume and end-diastolic volume
index . respectively ; EF
-
ejection fraction ; ESVI = end-systolic volume
index ; LV
-
left ventricular; PFR
=
peak filling rate ; RV
=
right ventricular;
SY and SVI
-
stroke volume and stroke volume index, respectively ; Tr
time to,
persisted at peak exercise. Neither group had a significant
increase in left ventricular ejection fraction during exercise .
Right ventricular ejection fraction did not differ between the
two groups at rest or at peak exercise and did not change
with exercise in either group.
Despite the normalization of rest left ventricular ejection
fraction to >0.50 before exercise testing, the patients, in
contrast to the control group, demonstrated increased rest
and exercise left ventricular volumes at both end-systole and
end-diastole (Table 3). However, left ventricular stroke
volume in the patients did not differ from values in the
control group at rest or peak exercise.
Red and ventricularfticaW function. The
patient group also demonstrated impaired left ventricular
diastolic function manifested as abnormalities in ventricular
filling
. Averaged filling curves normalized to the diastolic
filling period for each group are shown in Figure 1 . Left
ventricular filling was greater in the control than in the
patient group at all filling intervals between 40% and 90% .
100
80
20
* Normal controls
o Cardiomyopathy
patients
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Figure 1 . Averaged diastolic filling curves for 18 normal control
subjects and 18 patients with a history of dilated cardiomyopathy .
Filling values are mean value ± SEM . *p < 0.05 cardiotnyopathy
versus control group .
The difference in percent filling was maximal at 50% of the
diastolic filling interval (69 ± 3% vs . 59 ± 13%, p < 0 .05,
Table 3). This impairment in early filling was also reflected as
a greater atria) contribution to diastolic filling (26 ± 3% vs .
40 ± 5%, p < 0.05, Table 3) .
Left ventricular peak filling rate normalized for end-
diastolic volume or stroke volume was slower in the patient
group (Table 3) . At peak exercise, peak filling rate increased
in both groups, although the difference between the patient
and control groups persisted only when peak filling was
normalized for end-diastolic volume . Time to peak left
ventricular filling was prolonged in the patients at both rest
and peak exercise .
Cons of patients relative to exercise ejection fraction
response (Table 4). A wide range of responses to exercise
was noted in the patient group despite apparently normal left
ventricular function at rest . Two subgroups were identified
on the basis of left ventricular response to exercise . In group
A (Patients 2, 4, 5, 7 to 9 and 18) left ventricular ejection
fraction increased during exercise (by >0.05) ; in Group B it
showed no change (Patients 1, 6, 10, 13 to 15 and 17) or
decreased (Patients 3, 11, 12 and 16). Left ventricular
ejection fraction at rest did not differ between groups A and
B. There was no difference in the mean age of the two
groups, but the proportion of women was greater in group B
than in group A . There was no difference between groups in
the frequency of positive biopsy findings for myocarditis or
positive results of antimyosin scans, or in therapy with
digoxin or angiotensin-converting enzyme inhibitors . Blood
pressure and heart rate responses to exercise were similar in
the two groups. Although exercise capacity, as measured by
peak work load and oxygen consumption at peak exercise,
was higher in group A than in group B, no difference was
noted between the two groups when oxygen consumption
Control
Group
Cardiomyopathy
Group
LV EF
Rest
0.62 ± 0.01 0.54 ± 0.021
Exercise
0.66 ± 0
.02 0.53 ± 0.03t
RV EF
Rest
0.44 ± 0.02 0.42 ± 0.02
Exercise
0.47 ± 0.02 0.46 *_ 0.02
LV EDVI (mllm')
Rest 65±3
77±4t
Exercise 76 2:3 0
90 ± Sot
LV ESVI (MUM)
Rest
25±1 36±3t
Exercise
27±2 43±4't
LV SVI (m)Im')
Rest
40±2 41 ±2
Exercise
50±2 0 47±3*
% filling at 50% diastole 69±3
59±3t
% atrial contribution to filling 26±3
40±5t
PFR (EDVIs)
Rest 3A±0.2 2.7±0.2t
Exercise
6.3 ±0,3° 4.9±0.3't
PFR (SVIs)
Rest 5.6±0,3 4.9±0.2t
Exercise 9.8±0.3* 9.0±0.5*
PFR (mils)
Rest 395 ± 31 372 ± 38
Exercise 662 ± 28' 813 ± 90'
TT PFR (ms)
Rest IM ±7 189±1St
Exercise 103 ± 4* 125 ± 7*t
;ACC Vol . 24, No. 2
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Table 4. Demographic, Exercise and Radionuclide Data for
Cardiomyopathy Subgroups
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*p < 0 .05, exercise versus rest . t p < 0 .05, cardiomyopathy versus control
group . Abbreviations as in Tables 2 and 3 .
was expressed as a fraction of the predicted maximum based
on age, gender, height and weight .
Although left ventricular end-diastolic and end-systolic
volume indexes at rest did not differ between the two patient
subgroups, these indexes increased at peak exercise in group
B but not in group A . With exercise, left ventricular stroke
volume index increased in group A, but was unchanged in
group B .
When the results of exercise testing in groups A and B
were compared with those in age- and gender-matched
subgroups of the control subjects, the lack of increase in left
ventricular end-diastolic and end-systolic volume indexes
with exercise was similar in group A and its control sub-
group. Group B differed from its control group in both the
increase in end-systolic volume and the lack of increase in
stroke volume index . Despite these differences in the hemo-
dynamic response to exercise, both peak oxygen consump-
tion and oxygen consumption at the anaerobic threshold,
when expressed as a fraction of maximal predicted oxygen
consumption, were lower in both groups A and B than in
their respective control subgroups.
A differential response was also observed between groups
A and B in right ventricular function during exercise . Al-
though right ventricular ejection fraction did not differ
between groups at rest, during exercise it increased signifi-
cantly in group A but was unchanged in group B .
Two group B patients (Patients 11 and 12) developed
symptoms of heart failure and a decrease in left ventricular
ejection fraction at rest 4 and 9 months, respectively, after
study .
Discussion
Although patients with dilated cardiomyopathy usually
have a poor prognosis and an annual mortality rate of 7% to
100/c due to either progressive heart failure or arrhythmia
(4-.6), individual patients may differ with respect to both
clinical course and degree of residual ventricular dysfunc-
tion . This study investigated rest and exercise ventricular
function in a group of patients who initially presented
predominantly with heart failure but were subsequently
observed to have clinically recovered, as judged by the
resolution of symptoms and the finding of a normal left
ventricular ejection fraction on either an echocardiogram or
a radioniclide ventriculogram .
Time course of recovery . The mean duration of symptoms
before recovery of ventricular function varied widely in
these patients ; although the time to normalization of left
ventricular ejection fraction was :s4 months, in most pa-
tients, in several it exceeded I year . This time course is in
agreement with the findings of Figulla and colleagues (6),
who found that some patients with dilated cardiomyopathy
continued to show improvement as long as 3 years after the
onset of their disease . Their observations and the present
study suggest that a subgroup of patients with stable symp-
toms may recover without aggressive intervention or the
need for transplantation after a period of medical therapy .
The principal morphologic feature observed on endomyocar-
dial biopsy that characterized patients with a favorable
prognosis was the loss of <35% of myofibril volume (6) .
Role of cadomyocardial biopsy and antimyosin imaging .
Dilated cardiomyopathy is often thought to represent the
aftermath of myocarditis, and indeed 4 (33%) of patients who
underwent biopsy in our study did have evidence for myo-
cardial inflammation and necrosis at the time of presenta-
tion . This incidence of myocarditis is similar to that we (3)
and others (l8) have previously described . Indium- I I I an-
timyosin antibody cardiac imaging has been proposed (11) as a
noninvasive technique to identify patients with dilated cardio-
myopathy and myocardial necrosis who are more likely to have
improvement in left ventricular ejection fraction. The present
study expands on those findings, as the majority of patients
(67%) who underwent scintigraphy had positive scan results
and the duration of symptoms was shorter in patients with
than in those without antimyosin antibody uptake . This
observation further supports the hypothesis that patients
with active necrosis at the time of presentation with ventric-
ular dilation and dysfunction may be the group with the best
overall prognosis . The apparently contradictory finding of
improvement in several patients without evidence for myo-
cardial necrosis may be partially explained by the observa-
tion that two of the four patients in this group who had
negative scan results were thought to have alcoholic cardio-
Group A Group B
(u=7) (n=11)
Age Qr1 38¢4 48±5
Male/female 64 3101
Peak work load (W) 175 ± 19 102 ± 16t
Peak 02 consumption (mi/kg per min)
Actual 21 .3 ± 2.0 15.4 ® Lit
% predicted 58 ± 4 49 ± 5
0, consumption at AT (mllkg per min)
Actual 11 .4 ± 19 10.8 ± 0 .5
% predicted peak C 2 consumption 31 ± 3 34 :t 3
LV EF
Rest 0 .58 ± 0.03 0 .51 ± 0.03
Exercise 0 .65 ± 0.03* 0 .45 ± 0.03t
RV EF
Rest 0.42 ± 0 .02 0,42 ± 0 .03
Exercise 0 .52 ± 0.02* 0,43 ± 0 .02t
LV EDVI (ml/m')
Rest 75 ± 5 5 ± 5
Exercise 116 ± 7 94 ± 0,
LV ESVI (mYm 2 )
Rest 32 ± 2 40 ± 5t
Exercise 33 ± 5 51 ± 6*t
LV SVI Win)
Rest 43 ± 5 39 = 3
Exercise 53 ± 6* 43 ± 3
4(8
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myopathy, a process that is often reversible on cessation of
exposure to the toxic substance (19) .
Aboonnalides in exercise ce . All patients en-
rolled in this study had a normal left ventricular ejection
fraction at rest and were in functional class I at the lime of
exercise: testing
. Although the patient group had a peak work
load during upright bicycle exercise similar to that of the
control group, their exercise physiology was abnormal, as
oxygen consumption at peak exercise was only 53% of the
predictedd level. Although deconditioning as a result of a
sedentary life-style could explain this limitation, the control
group excluded subjects who regularly exercised . Gas ex-
change analysis showed that the patient group reached the
anaerobic threshold at only 33% of predicted peak oxygen
consumption, suggesting either a central cardiovascular limit
to exercise (20) or persistent abnormalities of aerobic skel-
etal muscle metabolism that occur in patients with heart
failure (21,22) . Skeletal muscle in patients with heart failure
demonstrates increased glycolylic metabolism despite nor-
mal blood flow and oxygen delivery (22), and persistence of
this increase after the recovery of central ventricular func-
tion could lead to a low oxygen consumption at the anaero-
bic threshold . We also considered the possibility that the
stress of exercise revealed abnormalities in cardiac function
despite the apparent normalization of left ventricular ejec-
tion fraction at rest. The heart rate response to exercise was
normal, arguing against the abnormality of myocardial sen-
sitivity to beta-adrenergic stimulation that is seen in patients
with symptomatic heart failure (23) and contributes to their
exercise intolerance (24) . We further assessed cardiac func-
tion with first-pass radionuclide ventriculography .
Abnormalities In ventricular function at rest . Although
patients were enrolled in this study on the basis of routine
echocurdiographic or equilibrium radionuclide ventriculo-
graphic evidence of normal left ventricular systolic function,
a more detailed examination by first-pass radionuclide ven«
tricul phy revealed persistent abnormalities of myocar-
dial systolic and diastolic function . Left ventricular ejection
fraction at rest after recovery, as assessed by first-pass
radionuclide angiography, remained lower than that of age-
and gender-matched control subjects . In addition, it was
lower despite the presence of persistent ventricular dilation
and, in many patients, concurrent treatment with vasodila-
tors, although both factors tend to increase the measured
ejection fraction at a given level of myocardial contractility .
Diastolic function at rest was abnormal in the patient
group, as peak left ventricular filling rate normalized to
either end-diastolic volume or stroke volume was depressed .
The fraction of left ventricular filling at 50% of diastole was
also depressed, and the contribution of atrial filling to overall
diastolic filling was increased in comparison with that in
control subjects. These abnormalities in diastolic function
are similar to those reported (16) in patients with restrictive
cardiomyopathy and may be due to chronic alterations in
ventricular distensibility or compliance, or both . Distensibil-
ity in these patients might be altered by the presence of
JACC Vol. 24, No . 2
residual myocardial fibrosis or edema. In fact, replacement
and interstitial fibrosis are frequently found in patients who
have recovered from myocarditis and were follow-up biopsy
findings in all four of our patients with myocarditis as well as
in most of the patients without myocarditis . Even if ventric-
ular distensibility were unchanged, the persistent ventricular
dilation in these patients would result in the occurrence of
ventricular filling on a less compliant portion of the diastolic
pressure-volume relation. Studies of the diastolic pressure-
volume relation in these patients would be necessary to
further elucidate the etiology of the persistent diastolic
abnormalities .
Abnormalities in exercise ventricular function . The abnor-
malities in left ventricular systolic function seen at rest
persisted during upright bicycle exercise . Although left
ventricular ejection fraction did not significantly augment at
peak exercise in either group, left ventricular end-systolic
volume increased only in the patient group . Higgenbotham
et al . (25) have de sonstrated that in women, who composed
50% of our study group, left ventricular ejection fraction
does not normally increase with upright bicycle exercise ;
however, stroke volume increases as a result of an increase
in end-diastolic volume without an increase in end-systolic
volume. Thus, the increase in end-systolic volume observed
in our patient group at a similar peak systolic pressure argues
for an impairment in ventricular contractility at peak exer-
cise. However, in contrast to patients with severe left
ventricular dysfunction (24), our patients retained the ability
to increase stroke volume with exercise in a manner similar
to that of the control group . This increased stroke volume
was achieved despite increased end-systolic volume because
of a greater increase in end-diastolic volume than that
observed in the control group .
The prolongation in time to peak left ventricular filling
was present at rest in the patient group and persisted at peak
exercise. Because the time from end-systole to peak filling
includes both isovolumetric relaxation and early ventricular
filling, prolongation of this interval may reflect abnormalities
in either or both of these phases of diastole . Similar prolon-
gation in time to peak left ventricular filling during exercise
has been observed in patients with coronary artery disease
(26) or ventricular hypertrophy (27) . Prolongation of the
intracellular calcium transient has been observed in isolated
human myocardium from patients with severe heart failure
(28) . The prolongation in time to peak left ventricular filling
observed in our patients may reflect persistence of this
biochemical abnormality .
In an effort to learn more about the persistent abnormal-
ities in ventricular function with exercise, we classified the
patients with cardiomyopathy into two subgroups : patients
with (group A) or without (group B) a >0 .05 increase in left
ventricular ejection fraction with exercise . Three principal
findings differentiated the two groups ; Group A patients had
an increase in right ventricular ejection fraction with exer-
cise; they had a greater increase in stroke volume index and
an increase in end-diastolic volume that was not accompa-
JACC Vol . 24, No. 2
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nied by the increase in end-systolic volume seen in group 8
patients . Considering the similar levels of blood pressure in
both groups, this increase in end-systolic volume in group B
suggests a persistent abnormality in the ability of contractil-
ity to increase during exercise . Although the hemodynamic
responses of the two groups may have differed in part
because of the greater proportion of women in group B, the
observation (25) that end-systolic volume does not increase
in normal women during exercise suggests that gender
differences alone do not account for this difference .
Study limitations . We were unable to observe serial
changes in ventricular function and exercise performance in
these patients during recovery from acute cardiomyopathy,
as exercise data were not obtained when the patients initially
presented. Acquisition of such data will require studies of a
large number of patients in order to include those who will
recover . The use of antimyosin scintigraphy or endomyocar-
dial biopsy may be helpful, as it allows the prospective
identill,zation of patients in whom recovery will be more
likely (11).
Despite the apparent clinical normalization of left ventric-
!.iar ejection fraction in patients who were thought to have
recovered from dilated cardiomyopathy, there was still a
difference between the ejection fraction obtained on first-
pass radionuclide scan and that obtained by equilibrium scan
or echocardiography before study . haul et al . (15) demon-
strated a difference of 0 .09 between the ejection fraction
measurements obtained by the two techniques in patients with
a normal ejection fraction . This difference is largely due to the
use of a fixed region of interest in first-pass scanning, which
would tend to lead to an overestimation of the end-systolic
volume. As the results of echocardiographic measurements of
ejection fraction are similar to those of equilibrium ventricu-
lography, it would be expected that the first-pass radionu-
clide ejection fraction would be lower than that obtained on
clinical evaluation .
The increased end-diastolic volume in the patient group
might be expected to lead to a decreased value for peak filling
rate normalized for end-diastolic volume without necessarily
reflecting a true difference in ventricular filling . Nonetheless,
rest peak filling rate normalized to stroke volume was also
lower in the patient group, supporting the presence of an
impairment of early diastolic filling in these patients, as
stroke volume was similar in the two groups .
Long-term prognosis and implications for therapy . The
prognosis of these patients who have recovered from an
episode of dilated cardiomyopathy appears to be favorable,
despite persistent abnormalities in systolic and diastolic
function. The majority of these patients are currently in
functional class I, and there have been no deaths or hospital
admissions for recurrent heart failure
. Nonetheless, the ob-
servation that two patients have experienced recurrent heart
failure symptoms and a decrease in left ventricular ejection
fraction at rest argues for continued close medical follow-up .
Several large scale studies have recently been published
on the use of angiotensin-converting enzyme inhibitor ther-
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apy in patients with asymptomatic lefi ventricular dysfunc-
tion. Pfeffer et al . (29) found improved survival in asymptom-
atic patients with impaired left ventricular function who were
given captopril therapy after myocardial infarction
. The
SOLVD investigators (7) found a decreased incidence of
symptomatic heart failure in previously asymptomatic pa-
tients with impaired left ventricular function who were given
enalapril therapy. Although these results are derived from
patients with impaired left ventricular systolic function pre-
dominantly due to ischemic heart disease, it is possible that
a beneficial effect may also occur in patients such as those
studied here who have persistent left ventricular dilation and
dysfunction after recovering from a severe insult such as
acute dilated cardiomyopathy .
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